Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling

Feng,Zhi-Yun; He,Zhen-Nian; Zhang,Bin; Chen,Zhong

doi:10.3892/mmr.2013.1717

Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling

Authors:
- Zhi-Yun Feng
- Zhen-Nian He
- Bin Zhang
- Zhong Chen
View Affiliations

Affiliations: Department of Orthopedics, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China, Department of Orthopedics, Beilun People's Hospital, Ningbo, Zhejiang 315806, P.R. China
Published online on: October 8, 2013 https://doi.org/10.3892/mmr.2013.1717
Pages: 1669-1679

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The involvement of osteoprotegerin (OPG) in bone metabolism has previously been established; however, whether OPG regulates chondrocytes directly and exerts precise cellular and molecular effects on chondrocytes remains to be determined. Thus, the present study aimed to investigate the direct effect of OPG on the viability, proliferation and functional consequences of chondrocytes. Primary chondrocytes were isolated from the knee of Sprague‑Dawley rats. Passage 1 chondrocytes were identified by toluidine blue staining and used in the experiments. The cell proliferation induced by OPG at various concentrations was measured by a Cell Counting kit-8 (CCK‑8) assay. Following pretreatment with mitogen-activated/extracellular signal‑regulated kinase kinase (MEK) inhibitor U0126, extracellular signal‑regulated kinase (ERK) inhibitor PD098059, and P38 mitogen‑activated protein kinase (P38MAPK) inhibitor SB203580 for 30 min, chondrocytes were treated with OPG, and CCK‑8 was performed. The cellular signals of MAPKs, including ERK, P38MAPK and c‑Jun N‑terminal protein kinase (JNK), were investigated by western blot analysis following treatment with OPG. The functional consequences following treatment with soluble OPG were analyzed by qPCR and western blot analysis. OPG increased chondrocyte proliferation with maximal effect at 10 ng/ml, and induced the phosphorylation of MEK and ERK but not P38MAPK or JNK. Suppression of ERK activity via PD098095 inhibited OPG-induced chondrocyte proliferation. Administration of OPG significantly downregulated ADAMTS‑5 and upregulated tissue inhibitor of metalloproteinase (TIMP)‑4 production, but had no effect on the expression of TIMP‑1, ‑2 and ‑3, insulin‑like growth factor I, transforming growth factor‑β, basic fibroblast growth factor, bone morphogenetic protein‑2, collagen II, aggrecan and ADAMTS‑4. Suppression of ERK activity via PD098095 inhibited the alteration of ADAMTS‑5 and TIMP‑4 expression induced by OPG. OPG therefore regulated the proliferation of chondrocytes via MEK/ERK signaling, and directly affected chondrocytes by influencing the expression profile of ADAMTS‑5 and TIMP‑4.

View Figures

View References

1	Kobayashi-Sakamoto M, Isogai E and Holen I: Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells. Eur J Haematol. 85:26–35. 2010.PubMed/NCBI
2	Kadri A, Ea HK, Bazille C, Hannouche D, Lioté F and Cohen-Solal ME: Osteoprotegerin inhibits cartilage degradation through an effect on trabecular bone in murine experimental osteoarthritis. Arthritis Rheum. 58:2379–2386. 2008. View Article : Google Scholar
3	Komuro H, Olee T, Kühn K, et al: The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage. Arthritis Rheum. 44:2768–2776. 2001. View Article : Google Scholar : PubMed/NCBI
4	Kong YY, Yoshida H, Sarosi I, et al: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:315–323. 1999. View Article : Google Scholar : PubMed/NCBI
5	Shimizu S, Asou Y, Itoh S, et al: Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis. Arthritis Rheum. 56:3358–3365. 2007. View Article : Google Scholar
6	Kong YY, Feige U, Sarosi I, et al: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 402:304–309. 1999. View Article : Google Scholar : PubMed/NCBI
7	Kwan Tat S, Pelletier JP, Lajeunesse D, Fahmi H, Lavigne M and Martel-Pelletier J: The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol. 26:295–304. 2008.
8	Kwan Tat S, Amiable N, Pelletier JP, et al: Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis. Rheumatology (Oxford). 48:1482–1490. 2009.PubMed/NCBI
9	Yongchaitrakul T, Manokawinchoke J and Pavasant P: Osteoprotegerin induces osteopontin via syndecan-1 and phosphoinositol 3-kinase/Akt in human periodontal ligament cells. J Periodontal Res. 44:776–783. 2009. View Article : Google Scholar : PubMed/NCBI
10	Goldring MB and Marcu KB: Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther. 11:2242009. View Article : Google Scholar : PubMed/NCBI
11	Lories RJ and Luyten FP: The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol. 7:43–49. 2011. View Article : Google Scholar : PubMed/NCBI
12	Verma P and Dalal K: ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem. 112:3507–3514. 2011. View Article : Google Scholar : PubMed/NCBI
13	Li X, Peng J, Wu M, et al: BMP2 promotes chondrocyte proliferation via the Wnt/β-catenin signaling pathway. Mol Med Rep. 4:621–626. 2011.PubMed/NCBI
14	Kotake S, Udagawa N, Hakoda M, et al: Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum. 44:1003–1012. 2001. View Article : Google Scholar : PubMed/NCBI
15	Rubinfeld H and Seger R: The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol. 31:151–174. 2005. View Article : Google Scholar : PubMed/NCBI
16	Dai Y, Rahmani M, Pei XY, et al: Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNK. Blood. 105:1706–1716. 2005. View Article : Google Scholar
17	Kimata M, Michigami T, Tachikawa K, et al: Signaling of extracellular inorganic phosphate up-regulates cyclin D1 expression in proliferating chondrocytes via the Na⁺/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway. Bone. 47:938–947. 2010. View Article : Google Scholar : PubMed/NCBI
18	Feng JQ, Xing L, Zhang JH, et al: NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem. 278:29130–29135. 2003. View Article : Google Scholar : PubMed/NCBI
19	Sun HZ, Yang TW, Zang WJ and Wu SF: Dehydroepiandrosterone-induced proliferation of prostatic epithelial cell is mediated by NFKB via PI3K/AKT signaling pathway. J Endocrinol. 204:311–318. 2010. View Article : Google Scholar : PubMed/NCBI
20	Liu S, Tan WY, Chen QR, et al: Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth. Cancer Sci. 99:952–957. 2008. View Article : Google Scholar : PubMed/NCBI
21	Massoumi R, Chmielarska K, Hennecke K, Pfeifer A and Fässler R: Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell. 125:665–677. 2006. View Article : Google Scholar : PubMed/NCBI
22	Glasson SS, Askew R, Sheppard B, et al: Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature. 434:644–648. 2005. View Article : Google Scholar : PubMed/NCBI
23	Zhou Y, Millward-Sadler SJ, Lin H, et al: Evidence for JNK-dependent up-regulation of proteoglycan synthesis and for activation of JNK1 following cyclical mechanical stimulation in a human chondrocyte culture model. Osteoarthritis Cartilage. 15:884–893. 2007. View Article : Google Scholar : PubMed/NCBI
24	Kita K, Kimura T, Nakamura N, Yoshikawa H and Nakano T: PI3K/Akt signaling as a key regulatory pathway for chondrocyte terminal differentiation. Genes Cells. 13:839–850. 2008. View Article : Google Scholar : PubMed/NCBI
25	Bursell L, Woods A, James CG, Pala D, Leask A and Beier F: Src kinase inhibition promotes the chondrocyte phenotype. Arthritis Res Ther. 9:R1052007. View Article : Google Scholar : PubMed/NCBI
26	Dong YF, Soung do Y, Chang Y, et al: Transforming growth factor-beta and Wnt signals regulate chondrocyte differentiation through Twist1 in a stage-specific manner. Mol Endocrinol. 21:2805–2820. 2007. View Article : Google Scholar
27	Ryan JA, Eisner EA, DuRaine G, You Z and Reddi AH: Mechanical compression of articular cartilage induces chondrocyte proliferation and inhibits proteoglycan synthesis by activation of the ERK pathway: implications for tissue engineering and regenerative medicine. J Tissue Eng Regen Med. 3:107–116. 2009. View Article : Google Scholar
28	Yonekura A, Osaki M, Hirota Y, et al: Transforming growth factor-beta stimulates articular chondrocyte cell growth through p44/42 MAP kinase (ERK) activation. Endocr J. 46:545–553. 1999. View Article : Google Scholar : PubMed/NCBI
29	Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T and Takigawa M: CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem. 268:6058–6065. 2001. View Article : Google Scholar
30	Kobayashi-Sakamoto M, Isogai E, Hirose K and Chiba I: Role of alphav integrin in osteoprotegerin-induced endothelial cell migration and proliferation. Microvasc Res. 76:139–144. 2008. View Article : Google Scholar : PubMed/NCBI
31	Toffoli B, Bernardi S, Candido R, et al: Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. Mol Cell Endocrinol. 331:136–142. 2011. View Article : Google Scholar : PubMed/NCBI
32	Candido R, Toffoli B, Corallini F, et al: Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. J Vasc Res. 47:252–261. 2010. View Article : Google Scholar : PubMed/NCBI
33	Bradley EW and Drissi MH: WNT5A regulates chondrocyte differentiation through differential use of the CaN/NFAT and IKK/NF-kappaB pathways. Mol Endocrinol. 24:1581–1593. 2010. View Article : Google Scholar : PubMed/NCBI